Parut Bhimalli, MD
Pain Medicine · Carson City, MINPI 1821050790
Payments from drug & device makers
Across 158 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$484
- Boston Scientific$401
- Collegium Pharmaceutical, Inc.$274
- Abbott$252
- Pfizer$227
- GRT US Holding, Inc.$189
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,851100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $484 |
| Boston Scientific | 7 | $401 |
| Collegium Pharmaceutical, Inc. | 20 | $274 |
| Abbott | 13 | $252 |
| Pfizer | 12 | $227 |
| GRT US Holding, Inc. | 10 | $189 |
| Averitas Pharma Inc. | 5 | $107 |
| Medtronic | 5 | $103 |
| Vertos Medical, Inc. | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 8 | $99 |
| Biohaven Pharmaceuticals, Inc. | 7 | $97 |
| Amgen | 6 | $86 |
| Biodelivery Sciences International, Inc. | 5 | $65 |
| Assertio Therapeutics, Inc. | 4 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Lilly USA, LLC | 3 | $34 |
| Almatica Pharma LLC | 2 | $33 |
| Neurocrine Biosciences, Inc. | 2 | $29 |
| Bioventus LLC | 2 | $28 |
| Novartis | 2 | $28 |
| Nevro Corp. | 1 | $23 |
| Avanos Medical | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Tonix Medicines, Inc. | 1 | $14 |
| Upsher-smith Laboratories LLC | 1 | $11 |
How this compares
$2,851 in reported general payments places this provider in the 55th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 32 | $6,489 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 192 | $2,459 |
| Naloxone Hcl | 15 | $1,013 |
| Gabapentin | 81 | $678 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $482 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $440 |
| Pregabalin | 42 | $418 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 49 | $377 |
| Cyclobenzaprine Hcl | 19 | $296 |
| Methocarbamol | 25 | $251 |
| Diclofenac Sodium | 12 | $239 |
| Tramadol Hcl | 61 | $161 |
| Meloxicam | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Carson City
- Joel SaperAnn Arbor$5.7M
- Harry SukumaranRochester Hills$308K
- Bindu Popat LewisGrand Rapids$135K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$72K
- Alexander TurfeWyandotte$41K
- Eric KozfkayWyoming$28K
- Michael SikorskyBloomfield Hills$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.